Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar

NCT00594347 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Streptococcus Pneumoniae

Interventions

BIOLOGICAL: Pneumo 23
BIOLOGICAL: Prevnar

Sponsor

Sanofi Pasteur, a Sanofi Company